REVANCE THERAPEUTICS, INC.


SEC Filings
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Current Reports
8-K
2024-03-05
EX-1.1
8-K
2024-02-28
EX-10.1
8-K
2024-02-13
EX-10.1
8-K
2024-01-08
EX-99.1

Proxy Statements
DEF 14A
2024-03-21

Beneficial Ownership Report
13G/A
2024-02-14
13G/A
2024-02-13

Recent Insider activity

Subsidiaries
EX-21.1
2024-02-28
EX-21.1
2022-02-28
EX-21.1
2021-02-25
EX-21.1
2020-02-26
EX-21.1
2019-02-28
EX-21.1
2018-03-02
EX-21.1
2016-03-04
Debug Info- Version: 2.6